Acute Lymphoblastic Leukemia: Pharmacologic Management
Acute lymphoblastic leukemia (ALL) is the most prevalent pediatric leukemia and makes up one-quarter of cancer cases among adolescents and children younger than 15 years.
Diagnosis & Disease Information
Anal Cancer: Pharmacologic Management
Anal cancer, of which fewer than 10,000 patients are diagnosed annually in the United States, is an uncommon type of cancer occurring in the tissue of the anus.
Bladder Cancer Guidelines
The best bladder cancer treatment option may include more than one type or combination of different treatments (chemotherapy, radiation, and surgery)
Bladder Cancer: Pharmacologic Management
Bladder cancer is the sixth most prevalent cancer in the United States. As of 2023, 82,290 new diagnoses of bladder cancer (62,420 in men and 19,870 in women) were documented, as well as 16,710 deaths.
Bone Cancer: Pharmacologic Management
Primary bone cancers are rare cancers that arise from primitive mesenchymal cells from which all connective tissues are derived. Bone cancer accounts for 0.2% of all cancers.
Breast Cancer: Pharmacologic Management
The National Cancer Institute estimates that there will be 297,790 new cases of invasive breast cancer and 55,720 new cases of ductal carcinoma in situ (DCIS) diagnosed in 2023.
Colon Cancer Guidelines
Colon cancer is the third most common cancer diagnosed in the United States. The overall lifetime risk of developing colorectal cancer is approximately 1 in 23 for men and 1 in 25 in women. Learn more about the staging, management, and prognosis of colon cancer.
Colorectal Cancer: Pharmacologic Management
Colorectal cancer is the third most common cancer and the second leading cause of cancer death in the United States.1 Colorectal cancer is an umbrella term that refers to cancer of both the colon and the rectum.
Endometrial Cancer: Pharmacologic Management
Endometrial cancer is the most common type of gynecologic cancer in the United States, with approximately 66,000 new cases diagnosed in 2023.
Esophageal Cancer: Pharmacologic Management
Esophageal cancer accounts for 1.1% of all cancer cases and is the 11th leading cause of cancer death in the United States.
- Loading...
Loading...
Loading... 
Loading...